Datavault AI Inc. (NASDAQ: DVLT) has announced an exclusive licensing agreement with Wellgistics Health (NASDAQ: WGRX) for its proprietary smart contracts intellectual property. The IP will be integrated into Wellgistics’ PharmacyChain(TM) and EinsteinRx(TM) platforms, enabling Web 3.0 smart contract functions across a network of more than 6,500 pharmacies. This agreement supports Wellgistics’ plan to streamline prescription tracking, reduce pharmacy benefit manager (PBM)-driven costs, enhance transparency for payers, and modernize U.S. pharmaceutical distribution through data automation and AI integration.
According to the press release, the licensing deal allows Wellgistics to leverage Datavault AI’s smart contracts technology to automate and secure transactions within the pharmaceutical supply chain. By embedding smart contracts into the PharmacyChain and EinsteinRx platforms, the companies aim to reduce administrative burdens and improve efficiency for pharmacies and payers alike. The integration is expected to provide real-time tracking of prescriptions, automated verification of claims, and enhanced data integrity, ultimately lowering costs and increasing transparency.
Datavault AI, headquartered in Philadelphia, PA, is a leader in AI experience, valuation, and monetization of assets in the Web 3.0 environment. The company’s cloud-based platform includes Acoustic Science and Data Science Divisions. Its Acoustic Science Division features patented technologies like WiSA(R), ADIO(R), and Sumerian(R) for spatial and multichannel wireless HD sound transmission. The Data Science Division leverages Web 3.0 and high-performance computing for experiential data perception, valuation, and secure monetization. The company’s Information Data Exchange(R) (IDE) enables Digital Twins and secure attachment of physical objects to immutable metadata objects, fostering responsible AI.
The licensing agreement with Wellgistics underscores the growing adoption of blockchain and smart contract technology in healthcare. By integrating these capabilities into pharmacy operations, Wellgistics aims to address long-standing inefficiencies in drug distribution and payment reconciliation. The move is part of a broader trend toward digitization and automation in the pharmaceutical industry, driven by the need to reduce costs and improve patient outcomes.
For more details, the full press release is available at https://ibn.fm/MLaEZ. Investors seeking the latest updates on Datavault AI can visit the company’s newsroom at https://ibn.fm/DVLT.
This announcement highlights the potential of Web 3.0 technologies to transform healthcare logistics. As smart contracts become more prevalent in the sector, companies like Datavault AI and Wellgistics Health are positioned to drive innovation in prescription management and cost control. The partnership could serve as a model for future integrations of blockchain and AI in pharmaceutical supply chains.
